Travere Therapeutics: Q4 Earnings Insights

Travere Therapeutics TVTX reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Travere Therapeutics beat estimated earnings by 15.28%, reporting an EPS of $-0.61 versus an estimate of $-0.72.

Revenue was up $6.27 million from the same period last year.

Last quarter the company beat on EPS by $0.41 which was followed by a 8.35% increase in the share price the next day.

Here's a look at Travere Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.54	-0.68	-0.39	-0.47
EPS Actual	-0.13	-0.39	-0.55	-0.48
Revenue Estimate	60.93M	50.33M	50.09M	51.66M
Revenue Actual	68.22M	54.62M	47.41M	50.98M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.